The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Pseudomonas Aeruginosa: Resistance to the Max
Open accessAbstract
Pseudomonas aeruginosa is intrinsically resistant to a variety of antimicrobials and can develop resistance during anti-pseudomonal chemotherapy both of which compromise treatment of infections caused by this organism. Resistance to multiple classes of antimicrobials (multidrug resistance) in particular is increasingly common in P. aeruginosa, with a number of reports of pan-resistant isolates treatable with a single agent, colistin. Acquired resistance in this organism is multifactorial and attributable to chromosomal mutations and the acquisition of resistance genes via horizontal gene transfer. Mutational changes impacting resistance include upregulation of multidrug efflux systems to promote antimicrobial expulsion, derepression of ampC, AmpC alterations that expand the enzyme's substrate specificity (i.e., extended-spectrum AmpC), alterations to outer membrane permeability to limit antimicrobial entry and alterations to antimicrobial targets. Acquired mechanisms contributing to resistance in P. aeruginosa include β-lactamases, notably the extended-spectrum β-lactamases and the carbapenemases that hydrolyze most β-lactams, aminoglycoside-modifying enzymes, and 16S rRNA methylases that provide high-level pan-aminoglycoside resistance. The organism's propensity to grow in vivo as antimicrobial-tolerant biofilms and the occurrence of hypermutator strains that yield antimicrobial resistant mutants at higher frequency also compromise anti-pseudomonal chemotherapy. With limited therapeutic options and increasing resistance will the untreatable P. aeruginosa infection soon be upon us?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Aminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Multidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804
Pseudomonas aeruginosa – a phenomenon of bacterial resistance
Strateva, T., & Yordanov, D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009142-0 · Cited by 803
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides
Doi, Y., & Arakawa, Y. (2007) · Clinical Infectious Diseases · doi:10.1086/518605 · Cited by 571
Efflux pumps as antimicrobial resistance mechanisms
Poole, K. (2007) · Annals of Medicine · doi:10.1080/07853890701195262 · Cited by 562
Self-citationPseudomonas aeruginosa: a formidable and ever-present adversary
Kerr, K. G., & Snelling, A. M. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.04.020 · Cited by 549
Ko¨hler, T., Michéa‐Hamzehpour, M., Henze, U., Gotoh, N., Kocjancic Curty, L., & Pechère, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
Antimicrobial resistance of Pseudomonas aeruginosa biofilms
Drenkard, E. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.08.009 · Cited by 520
Emerging carbapenemases: a global perspective
Walsh, T. R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(10)70004-2 · Cited by 506
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
Pfeifer, Y., Cullik, A., & Witte, W. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.005 · Cited by 494
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms
Borriello, G., Werner, E., Roe, F., Kim, A. M., Ehrlich, G. D., & Stewart, P. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2659-2664.2004 · Cited by 476
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 470
Self-citationPoole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Self-citationMcPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Lambert, M.-L., Suetens, C., Savey, A., Palomar, M., Hiesmayr, M., Morales, I., Agodi, A., Frank, U., Mertens, K., Schumacher, M., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70258-9 · Cited by 443
Moskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Quale, J., Bratu, S., Gupta, J., & Landman, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1633-1641.2006 · Cited by 409
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
Hirsch, E. B., & Tam, V. H. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.49 · Cited by 406
Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa
Rossolini, G. M., & Mantengoli, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01161.x · Cited by 395
Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics
Zhang, L., & Mah, T.-F. (2008) · Journal of Bacteriology · doi:10.1128/jb.01655-07 · Cited by 385
Stratified Growth in Pseudomonas aeruginosa Biofilms
Werner, E., Roe, F., Bugnicourt, A., Franklin, M. J., Heydorn, A., Molin, S., Pitts, B., & Stewart, P. S. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.10.6188-6196.2004 · Cited by 384
An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal
Harmsen, M., Yang, L., Pamp, S. J., & Tolker-Nielsen, T. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00690.x · Cited by 376
Quinolones: Action and Resistance Updated
Drlica, K., Hiasa, H., Kerns, R., Malik, M., Mustaev, A., & Zhao, X. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630947 · Cited by 376
Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2233-2241.2000 · Cited by 371
Self-citationMauldin, P. D., Salgado, C. D., Hansen, I. S., Durup, D. T., & Bosso, J. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01041-09 · Cited by 360
Resistance to ?-lactam antibiotics
Poole, K. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4060-9 · Cited by 358
Self-citationPaterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504476 · Cited by 344
Fernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
Maciá, M. D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3382-3386.2005 · Cited by 309
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-09 · Cited by 307
Köhler, T., Epp, S. F., Curty, L. K., & Pechère, J.-C. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.20.6300-6305.1999 · Cited by 302
Falagas, M. E., Rafailidis, P. I., Ioannidou, E., Alexiou, V. G., Matthaiou, D. K., Karageorgopoulos, D. E., Kapaskelis, A., Nikita, D., & Michalopoulos, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.005 · Cited by 300
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-06 · Cited by 293
Trias, J., & Nikaido, H. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.52 · Cited by 291
P. aeruginosa Biofilms in CF Infection
Wagner, V. E., & Iglewski, B. H. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8079-9 · Cited by 288
Livermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 288
Walther-Rasmussen, J., & Høiby, N. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm226 · Cited by 271
Oliver, A., Baquero, F., & Blázquez, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02855.x · Cited by 267
Castanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., & Walsh, T. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4654-4661.2004 · Cited by 261
Jalal, S., Ciofu, O., Høiby, N., Gotoh, N., & Wretlind, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.710-712.2000 · Cited by 236
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 214
Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01410-08 · Cited by 211
Macfarlane, E. L. A., Kwasnicka, A., & Hancock, R. E. W. (2000) · Microbiology · doi:10.1099/00221287-146-10-2543 · Cited by 209
Gram-negative antibiotic resistance: there is a price to pay
Slama, T. G. (2008) · Critical Care · doi:10.1186/cc6820 · Cited by 206
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 205
Girlich, D., Naas, T., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2043-2048.2004 · Cited by 201
Outer Membranes and Efflux: The Path to Multidrug Resistance in Gram- Negative Bacteria
Poole, K. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378454 · Cited by 198
Self-citationPseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways
Hassett, D. J., Sutton, M. D., Schurr, M. J., Herr, A. B., Caldwell, C. C., & Matu, J. O. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.12.003 · Cited by 196
Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
Veesenmeyer, J. L., Hauser, A. R., Lisboa, T., & Rello, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ff137 · Cited by 196
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
Oliver, A., & Mena, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03250.x · Cited by 194
Molecular Basis of Azithromycin-Resistant Pseudomonas aeruginosa Biofilms
Gillis, R. J., White, K. G., Choi, K.-H., Wagner, V. E., Schweizer, H. P., & Iglewski, B. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3858-3867.2005 · Cited by 183
Haagensen, J. A. J., Klausen, M., Ernst, R. K., Miller, S. I., Folkesson, A., Tolker-Nielsen, T., & Molin, S. (2007) · Journal of Bacteriology · doi:10.1128/jb.00720-06 · Cited by 182
Shorr, A. F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ced02 · Cited by 181
Sobel, M. L., McKay, G. A., & Poole, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3202-3207.2003 · Cited by 179
Self-citationHenrichfreise, B., Wiegand, I., Pfister, W., & Wiedemann, B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00148-07 · Cited by 179
Sobel, M. L., Neshat, S., & Poole, K. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1246-1253.2005 · Cited by 176
Self-citationBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America
Pruett, T. (2010) · Yearbook of Surgery · doi:10.1016/s0090-3671(10)79814-1 · Cited by 176
Juan, C., Maciá, M. D., Gutiérrez, O., Vidal, C., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4733-4738.2005 · Cited by 175
Prevalence of multidrug-resistant organisms recovered at a military burn center
Keen, E. F., Robinson, B. J., Hospenthal, D. R., Aldous, W. K., Wolf, S. E., Chung, K. K., & Murray, C. K. (2010) · Burns · doi:10.1016/j.burns.2009.10.013 · Cited by 170
Zhanel, G. G., DeCorby, M., Adam, H., Mulvey, M. R., McCracken, M., Lagacé-Wiens, P., Nichol, K. A., Wierzbowski, A., Baudry, P. J., Tailor, F., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00469-10 · Cited by 166
Matthaiou, D. K., Michalopoulos, A., Rafailidis, P. I., Karageorgopoulos, D. E., Papaioannou, V., Ntani, G., Samonis, G., & Falagas, M. E. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181652fae · Cited by 163
Barrow, K., & Kwon, D. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00893-09 · Cited by 162
Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T., & Høiby, N. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.02.003 · Cited by 161
Srikumar, R., Paul, C. J., & Poole, K. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.5.1410-1414.2000 · Cited by 160
Self-citationCao, L., Srikumar, R., & Poole, K. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04210.x · Cited by 159
Self-citationTomás, M., Doumith, M., Warner, M., Turton, J. F., Beceiro, A., Bou, G., Livermore, D. M., & Woodford, N. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00816-09 · Cited by 159
Cantón, R., Cobos, N., de Gracia, J., Baquero, F., Honorato, J., Gärtner, S., Alvarez, A., Salcedo, A., Oliver, A., & Garcia-Quetglas, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01217.x · Cited by 158
Kallen, A. J., Hidrón, A., Patel, J. B., & Srinivasan, A. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/652152 · Cited by 158
Extended-spectrum β-lactamases in North America, 1987–2006
Bush, K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01848.x · Cited by 150
Tam, V. H., Chang, K., Abdelraouf, K., Brioso, C. G., Ameka, M., McCaskey, L. A., Weston, J. S., Caeiro, J., & Garey, K. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01446-09 · Cited by 147
Maseda, H., Saito, K., Nakajima, A., & Nakae, T. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09367.x · Cited by 142
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa
Higgins, P. G. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00009-8 · Cited by 138
Dötsch, A., Becker, T., Pommerenke, C., Magnowska, Z., Jänsch, L., & Häußler, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-09 · Cited by 137
Hocquet, D., Nordmann, P., Garch, F. E., Cabanne, L., & Plésiat, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1347-1351.2006 · Cited by 136
Jeannot, K., Elsen, S., Köhler, T., Attree, I., van Delden, C., & Plésiat, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01107-07 · Cited by 136
Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening
Groote, V. N. D., Verstraeten, N., Fauvart, M., Kint, C. I., Verbeeck, A. M., Beullens, S., Cornélis, P., & Michiels, J. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01657.x · Cited by 134
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals
Celenza, G., Pellegrini, C., Caccamo, M., Segatore, B., Amicosante, G., & Perilli, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl055 · Cited by 130
Shawar, R. M., MacLeod, D. L., Garber, R. L., Burns, J. L., Stapp, J. R., Clausen, C. R., & Tanaka, S. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2877 · Cited by 129
Lodge, J., Minchin, S., Piddock, L. J. V., & Busby, S. J. W. (1990) · Biochemical Journal · doi:10.1042/bj2720627 · Cited by 127
Bugs, Biofilms, and Resistance in Cystic Fibrosis
Davies, J. C. (2009) · Respiratory Care · doi:10.4187/aarc0492 · Cited by 125
Prospects for the next anti-Pseudomonas drug
Page, M. G. P., & Heim, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.006 · Cited by 125
Picão, R. C., Poirel, L., Gales, A. C., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00453-09 · Cited by 124
Sadovskaya, I., VINOGRADOV, E. V., Li, J., Hachani, A., Kowalska, K., & Filloux, A. (2010) · Glycobiology · doi:10.1093/glycob/cwq047 · Cited by 123
MexZ-mediated regulation of multidrug efflux pump expression in by binding on the intergenic DNA
MATSUO, Y., EDA, S., Gotoh, N., Yoshihara, E., & Nakae, T. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.07.010 · Cited by 122
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality
Tumbarello, M., Repetto, E. C., Trecarichi, E. M., Bernardini, C., PASCALE, G. D., Parisini, A., Rossi, M., Molinari, M. P., Spanu, T., Viscoli, C., et al. (2011) · Epidemiology and Infection · doi:10.1017/s0950268810003055 · Cited by 120
β-Lactamases identified in clinical isolates ofPseudomonas aeruginosa
Zhao, W., & Hu, Z. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.481763 · Cited by 117
Wolter, D. J., Kurpiel, P. M., Woodford, N., Palepou, M.-F. I., Goering, R. V., & Hanson, N. D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00734-08 · Cited by 117
Aubert, D., Poirel, L., Chevalier, J., Léotard, S., Pagès, J., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1615-1620.2001 · Cited by 115
Xavier, D. E., Picão, R. C., Girardello, R., et al. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-217 · Cited by 115
nalD Encodes a Second Repressor of the mexAB-oprM Multidrug Efflux Operon of Pseudomonas aeruginosa
Morita, Y., Cao, L., Gould, V. C., et al. (2006) · Journal of Bacteriology · doi:10.1128/jb.01342-06 · Cited by 111
Lee, J., Lee, Y. S., Park, Y., & Kim, B. S. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.11.012 · Cited by 110
Acquired Carbapenem-Hydrolyzing Beta-Lactamases and their Genetic Support
Poirel, L., & Nordmann, P. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378427 · Cited by 110
Viedma, E., Juan, C., Acosta, J., Zamorano, L., Otero, J. R., Sanz, F., Cháves, F., & Oliver, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00900-09 · Cited by 110
Feliziani, S., Luján, A. M., Moyano, A. J., Sola, C., Bocco, J. L., Montanaro, P., Canigia, L. F., Argaraña, C. E., & Smania, A. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012669 · Cited by 104
Livermore, D. M., & Yang, Y.-J. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.4.775 · Cited by 101
Mandsberg, L. F., Ciofu, O., Kirkby, N. S., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00428-08 · Cited by 101
Metallo beta lactamases inPseudomonas aeruginosaand Acinetobacter species
Gupta, V. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.131 · Cited by 99
Poirel, L., Magalhães, M., Lopes, M., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1406-1409.2004 · Cited by 99
Sader, H. S., Reis, A. O., Silbert, S., & Gales, A. C. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01031.x · Cited by 98
Emergence of KPC-Producing Pseudomonas aeruginosa in the United States
Poirel, L., Nordmann, P., Lagrutta, E., Cleary, T., & Munoz-Price, L. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00513-10 · Cited by 96
Schwartz, T., Volkmann, H., Kirchen, S., Kohnen, W., Schön-Hölz, K., Jansen, B., & Obst, U. (2006) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2006.00100.x · Cited by 95
Montero, M., Horcajada, J. P., Sorlí, L., et al. (2009) · Infection · doi:10.1007/s15010-009-8342-x · Cited by 95
Extended-Spectrum Cephalosporinases: Structure, Detection and Epidemiology
Nordmann, P., & Mammeri, H. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.297 · Cited by 95
Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00029-7 · Cited by 95
MacLeod, D. L., Nelson, L. E., Shawar, R. M., Lin, B. B., Lockwood, L. G., Dirk, J. E., Miller, G. H., Burns, J. L., & Garber, R. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315312 · Cited by 95
Oliver, A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.009 · Cited by 94
Pournaras, S., Maniati, M. A., Spanakis, N., Ikonomidis, A., Tassios, P. T., Tsakris, A., Legakis, N. J., & Maniatis, A. N. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki296 · Cited by 90
Wang, J., Zhou, J., Qu, T., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.014 · Cited by 89
β-Lactamases: A Survey of Protein Diversity
Helfand, M. S., & Bonomo, R. A. (2003) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005033342181 · Cited by 86
nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa
Fukuda, H., Hosaka, M., Iyobe, S., Gotoh, N., Nishino, T., & Hirai, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.790 · Cited by 86
Paul, M., Yahav, D., Bivas, A., Fraser, A., & Leibovici, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005197.pub3 · Cited by 84
Shahcheraghi, F., Nikbin, V. S., & Feizabadi, M. M. (2009) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0880 · Cited by 75
Castanheira, M., Bell, J. M., Turnidge, J. D., Mathai, D., & Jones, R. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-08 · Cited by 73
A CTX-M extended-spectrum β-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia
al Naiemi, N., Duim, B., & Bart, A. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46704-0 · Cited by 72
Contribution of Oxygen-Limiting Conditions to Persistent Infection of Pseudomonas Aeruginosa
Schobert, M., & Tielen, P. (2010) · Future Microbiology · doi:10.2217/fmb.10.16 · Cited by 72
Wolter, D. J., Moland, E. S., Goering, R. V., Hanson, N. D., & Lister, P. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.05.004 · Cited by 70
Emergence of KPC-Producing Pseudomonas aeruginosa in Trinidad and Tobago
Akpaka, P. E., Swanston, W. H., Ihemere, H. N., Correa, A., Torres, J. A., Soto, J. T., Montealegre, M. C., Quinn, J. P., & Villegas, M. V. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00362-09 · Cited by 69
First Report of the Metallo-β-Lactamase SPM-1 in Europe
Salabi, A. A. E., Toleman, M. A., Weeks, J. L., Bruderer, T., Frei, R., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-09 · Cited by 69
Reinhardt, A. K., Köhler, T., Wood, P., Rohner, P., Dumas, J.-L., Ricou, B., & van Delden, C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01278-06 · Cited by 67
Okamoto, K., Gotoh, N., & Nishino, T. (2002) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0193-7 · Cited by 66
Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa
Tam, V. H., Schilling, A. N., LaRocco, M., Gentry, L. O., Lolans, K., Quinn, J. P., & Garey, K. W. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01674.x · Cited by 64
Libisch, B., Poirel, L., Lepšanović, Z., Mirović, V., Balogh, B., Pászti, J., Hunyadi, Z., Dobák, A., Füzi, M., & Nordmann, P. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00483.x · Cited by 63
Hocquet, D., Plésiat, P., Dehecq, B., Mariotte, P., Talon, D. R., & Bertrand, X. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01646-09 · Cited by 61
Boutoille, D., Corvec, S., Caroff, N., Giraudeau, C., Espaze, E., Caillon, J., Plésiat, P., & Reynaud, A. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00882-6 · Cited by 60
Waine, D. J., Honeybourne, D., Smith, E. G., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00357-08 · Cited by 60
Hächler, H., Santanam, P., & Kayser, F. H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1254 · Cited by 59
Zhanel, G. G., Hoban, D. J., Schurek, K. N., & Karlowsky, J. A. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.08.003 · Cited by 59
Hocquet, D., Roussel‐Delvallez, M., Cavallo, J.-D., & Plésiat, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01334-06 · Cited by 56
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review
Zilberberg, M. D., Chen, J., Mody, S. H., Ramsey, A. M., & Shorr, A. F. (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-45 · Cited by 49
Biddlecome, S., Haas, M. J., DAVIES, J. E., Miller, G. H., Rane, D. F., & Daniels, P. J. L. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.6.951 · Cited by 49
Endimiani, A., Luzzaro, F., Pini, B., Amicosante, G., Rossolini, G. M., & Toniolo, A. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-52 · Cited by 46
Kim, J., Park, Y.-J., Kwon, H. J., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn244 · Cited by 46
Antibiotic Therapy againstPseudomonas aeruginosain Cystic Fibrosis
Taccetti, G., Campana, S., Neri, A. S., Boni, V., & Festini, F. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.2.166 · Cited by 41
Galimand, M., Lambert, T., Gerbaud, G., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1456 · Cited by 39
Efflux Pump Contribution to Multidrug Resistance in Clinical Isolates of Pseudomonas aeruginosa
Kiser, T. H., Obritsch, M. D., Jung, R., et al. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.7.632 · Cited by 37
Effect of MexXY Overexpression on Ceftobiprole Susceptibility in Pseudomonas aeruginosa
Baum, E. Z., Crespo‐Carbone, S. M., Morrow, B. J., Davies, T. A., Foleno, B. D., He, W., Queenan, A. M., & Bush, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00018-09 · Cited by 35
Emergence and Dissemination of BEL-1-Producing Pseudomonas aeruginosa Isolates in Belgium
Bogaerts, P., Bauraing, C., Deplano, A., & Glupczynski, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01603-06 · Cited by 34
Poirel, L., Docquier, J., Luca, F. D., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00859-09 · Cited by 32
Li, H., Toleman, M. A., Bennett, P. M., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01093-07 · Cited by 30
Sabtcheva, S., Galimand, M., Gerbaud, G., Courvalin, P. M., & Lambert, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1584-1588.2003 · Cited by 29
Queenan, A. M., Shang, W., Bush, K., & Flamm, R. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00060-10 · Cited by 28
Samonis, G., Matthaiou, D. K., Kofteridis, D. P., Maraki, S., & Falagas, M. E. (2010) · Clinical Infectious Diseases · doi:10.1086/653009 · Cited by 26
Incidence and mechanisms of aminoglycoside resistance inPseudomonas aeruginosa serotype O11 isolates
Kettner, M., Kallová, J., Hletková, M., & Milosovic, P. (1995) · Infection · doi:10.1007/bf01713571 · Cited by 25
Mutlu, G. M., & Wunderink, R. G. (2006) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000244127.92612.b4 · Cited by 25
Morero, N. R., & Argaraña, C. E. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01411.x · Cited by 22
Réjiba, S., Aubry, A., Petit-Frère, S., Jarlier, V., & Cambau, E. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.6.749 · Cited by 10
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Metadata
- Authors
- Poole, K.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2011
- Volume
- 2
- Pages
- 65-65
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2057418340
- Cited by
- 948
- References
- 171
- FWCI
- 16.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.